Results
|
|
6381.
|
The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models. [electronic resource] by
- Na, Young-Soon
- Jung, Kyung-Ah
- Kim, Seung-Mi
- Hong, Yong Sang
- Ryu, Min-Hee
- Jang, Se Jin
- Moon, Dae Hyuk
- Cho, Dong-Hyung
- Kim, Jin Cheon
- Lee, Jung Shin
- Kim, Tae Won
Producer: 20111003
In:
Cancer chemotherapy and pharmacology vol. 68
Availability: No items available.
|
|
|
6382.
|
A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer. [electronic resource] by
- Shen, Jie
- Wei, Jia
- Wang, Hao
- Yue, Guofeng
- Yu, Lixia
- Yang, Yang
- Xie, Li
- Zou, Zhengyun
- Qian, Xiaoping
- Ding, Yitao
- Guan, Wenxian
- Liu, Baorui
Producer: 20150330
In:
Journal of translational medicine vol. 11
Availability: No items available.
|
|
|
6383.
|
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. [electronic resource] by
- Ng, Kimmie
- Meyerhardt, Jeffrey A
- Chan, Andrew T
- Sato, Kaori
- Chan, Jennifer A
- Niedzwiecki, Donna
- Saltz, Leonard B
- Mayer, Robert J
- Benson, Al B
- Schaefer, Paul L
- Whittom, Renaud
- Hantel, Alexander
- Goldberg, Richard M
- Venook, Alan P
- Ogino, Shuji
- Giovannucci, Edward L
- Fuchs, Charles S
Producer: 20150220
In:
Journal of the National Cancer Institute vol. 107
Availability: No items available.
|
|
|
6384.
|
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach. [electronic resource] by
- Badreldin, Waleed
- Krell, Jonathan
- Chowdhury, Simon
- Harland, Stephen J
- Mazhar, Danish
- Harding, Victoria
- Frampton, Adam E
- Wilson, Peter
- Berney, Daniel
- Stebbing, Justin
- Shamash, Jonathan
Producer: 20160620
In:
BJU international vol. 117
Availability: No items available.
|
|
|
6385.
|
Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF. [electronic resource] by
- Woo, Jong Kyu
- Kang, Ju-Hee
- Kim, BoRa
- Park, Byung Hee
- Shin, Kum-Joo
- Song, Seong-Won
- Kim, Jung Ju
- Kim, Hwan-Mook
- Lee, Sang-Jin
- Oh, Seung Hyun
Producer: 20160722
In:
Oncotarget vol. 6
Availability: No items available.
|
|
|
6386.
|
Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases. [electronic resource] by
- Mizugaki, Hidenori
- Fujiwara, Yutaka
- Yamamoto, Noboru
- Yagishita, Shigehiro
- Kitazono, Satoru
- Tanaka, Ayako
- Horinouchi, Hidehito
- Kanda, Shintaro
- Nokihara, Hiroshi
- Tsuta, Koji
- Asamura, Hisao
- Tamura, Tomohide
Producer: 20150119
In:
Japanese journal of clinical oncology vol. 44
Availability: No items available.
|
|
|
6387.
|
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial. [electronic resource] by
- Tabernero, Josep
- Van Cutsem, Eric
- Lakomý, Radek
- Prausová, Jana
- Ruff, Paul
- van Hazel, Guy A
- Moiseyenko, Vladimir M
- Ferry, David R
- McKendrick, Joseph J
- Soussan-Lazard, Karen
- Chevalier, Soazig
- Allegra, Carmen J
Producer: 20140303
In:
European journal of cancer (Oxford, England : 1990) vol. 50
Availability: No items available.
|
|
|
6388.
|
Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis. [electronic resource] by
- Vétillard, Alexandra
- Jonchère, Barbara
- Moreau, Marie
- Toutain, Bertrand
- Henry, Cécile
- Fontanel, Simon
- Bernard, Anne-Charlotte
- Campone, Mario
- Guette, Catherine
- Coqueret, Olivier
Producer: 20161006
In:
Oncotarget vol. 6
Availability: No items available.
|
|
|
6389.
|
Efficacy assessment of self-assembled PLGA-PEG-PLGA nanoparticles: Correlation of nano-bio interface interactions, biodistribution, internalization and gene expression studies. [electronic resource] by
- Dimchevska, Simona
- Geskovski, Nikola
- Koliqi, Rozafa
- Matevska-Geskovska, Nadica
- Gomez Vallejo, Vanessa
- Szczupak, Boguslaw
- Sebastian, Eneko San
- Llop, Jordi
- Hristov, Delyan R
- Monopoli, Marco P
- Petruševski, Gjorgji
- Ugarkovic, Sonja
- Dimovski, Aleksandar
- Goracinova, Katerina
Producer: 20180618
In:
International journal of pharmaceutics vol. 533
Availability: No items available.
|
|
|
6390.
|
|
|
|
6391.
|
|
|
|
6392.
|
|
|
|
6393.
|
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. [electronic resource] by
- Shapiro, Jeremy D
- Thavaneswaran, Subotheni
- Underhill, Craig R
- Robledo, Kristy P
- Karapetis, Christos S
- Day, Fiona L
- Nott, Louise M
- Jefford, Michael
- Chantrill, Lorraine A
- Pavlakis, Nick
- Tebbutt, Niall C
- Price, Timothy J
- Khasraw, Mustafa
- Van Hazel, Guy A
- Waring, Paul M
- Tejpar, Sabine
- Simes, John
- Gebski, Val J
- Desai, Jayesh
- Segelov, Eva
Producer: 20190611
In:
Clinical colorectal cancer vol. 17
Availability: No items available.
|
|
|
6394.
|
|
|
|
6395.
|
|
|
|
6396.
|
|
|
|
6397.
|
|
|
|
6398.
|
Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis. [electronic resource] by
- Yin, M-B
- Li, Z-R
- Tóth, K
- Cao, S
- Durrani, F A
- Hapke, G
- Bhattacharya, A
- Azrak, R G
- Frank, C
- Rustum, Y M
Producer: 20060523
In:
Oncogene vol. 25
Availability: No items available.
|
|
|
6399.
|
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. [electronic resource] by
- Norris, Murray D
- Smith, Janice
- Tanabe, Kara
- Tobin, Peter
- Flemming, Claudia
- Scheffer, George L
- Wielinga, Peter
- Cohn, Susan L
- London, Wendy B
- Marshall, Glenn M
- Allen, John D
- Haber, Michelle
Producer: 20051006
In:
Molecular cancer therapeutics vol. 4
Availability: No items available.
|
|
|
6400.
|
|